BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2544245)

  • 1. Phencyclidine and MK-801: a behavioral and neurochemical comparison of their interactions with dihydropyridine calcium antagonists.
    O'Neill SK; Bolger GT
    Brain Res Bull; 1989 Apr; 22(4):611-6. PubMed ID: 2544245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The phencyclidine (PCP) analog N-[1-(2-benzo(B)thiophenyl) cyclohexyl]piperidine shares cocaine-like but not other characteristic behavioral effects with PCP, ketamine and MK-801.
    Koek W; Colpaert FC; Woods JH; Kamenka JM
    J Pharmacol Exp Ther; 1989 Sep; 250(3):1019-27. PubMed ID: 2674416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.
    Tricklebank MD; Singh L; Oles RJ; Preston C; Iversen SD
    Eur J Pharmacol; 1989 Aug; 167(1):127-35. PubMed ID: 2550253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the behavioral and biochemical effects of the NMDA receptor antagonists, MK-801 and phencyclidine.
    Hiramatsu M; Cho AK; Nabeshima T
    Eur J Pharmacol; 1989 Aug; 166(3):359-66. PubMed ID: 2553433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative electroencephalographic and behavioral effects of phencyclidine, (+)-SKF-10,047 and MK-801 in rats.
    Marquis KL; Paquette NC; Gussio RP; Moreton JE
    J Pharmacol Exp Ther; 1989 Dec; 251(3):1104-12. PubMed ID: 2557412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enantiomer selectivity and the development of tolerance to the behavioral effects of the calcium channel activator BAY K 8644.
    O'Neill SK; Bolger GT
    Brain Res Bull; 1988 Dec; 21(6):865-72. PubMed ID: 2465070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lindane-induced convulsions in NMRI and OF1 mice: antagonism with (+)MK-801 and voltage-dependent calcium channel blockers.
    Tusell JM; Vendrell M; Serratosa J; Trullas R
    Brain Res; 1992 Oct; 593(2):209-14. PubMed ID: 1280523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phencyclidine-like discriminative stimulus properties of MK-801 in rats.
    Willetts J; Balster RL
    Eur J Pharmacol; 1988 Jan; 146(1):167-9. PubMed ID: 3280331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phencyclidine increases the affinity of dihydropyridine calcium channel antagonist binding in rat brain.
    Bolger GT; Rafferty MF; Skolnick P
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Sep; 330(3):227-34. PubMed ID: 2932650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel anticonvulsant MK-801 interacts with central phencyclidine recognition sites in rat brain.
    Loo PA; Braunwalder AF; Williams M; Sills MA
    Eur J Pharmacol; 1987 Mar; 135(2):261-3. PubMed ID: 3034630
    [No Abstract]   [Full Text] [Related]  

  • 11. MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys.
    Koek W; Woods JH; Winger GD
    J Pharmacol Exp Ther; 1988 Jun; 245(3):969-74. PubMed ID: 2838610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents.
    Bristow LJ; Hutson PH; Thorn L; Tricklebank MD
    Br J Pharmacol; 1993 Apr; 108(4):1156-63. PubMed ID: 8485625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of calcium antagonists on phencyclidine behaviors.
    Bolger GT; Rafferty MF; Crawley JN; Paul SM; Skolnick P
    Pharmacol Biochem Behav; 1986 Jul; 25(1):45-9. PubMed ID: 3749237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple Actions of Phencyclidine and (+)MK-801 on Isolated Bovine Cerebral Arteries.
    Wendling WW; Chen D; Wendling KS; Kamel IR
    J Neurosurg Anesthesiol; 2018 Oct; 30(4):359-367. PubMed ID: 29076977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel anticonvulsant MK-801: a potent and specific ligand of the brain phencyclidine/sigma-receptor.
    Sircar R; Rappaport M; Nichtenhauser R; Zukin SR
    Brain Res; 1987 Dec; 435(1-2):235-40. PubMed ID: 2827853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of carbachol-induced inositol phosphate accumulation by phencyclidine, phencyclidine-like ligands and sigma agonists involves blockade of the muscarinic cholinergic receptor: a novel dioxadrol-preferring interaction.
    Brog JS; Beinfeld MC
    J Pharmacol Exp Ther; 1990 Sep; 254(3):952-6. PubMed ID: 2203900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of MK-801 and phencyclidine on catecholamine uptake and NMDA-induced norepinephrine release.
    Snell LD; Yi SJ; Johnson KM
    Eur J Pharmacol; 1988 Jan; 145(2):223-6. PubMed ID: 3280329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of chemically and electrically-induced convulsions on [3H]nitrendipine binding in mouse brain.
    Weissman BA; Bolger GT
    Brain Res Bull; 1987 Dec; 19(6):673-8. PubMed ID: 2449938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acylating phencyclidines irreversibly enhance brain calcium antagonist binding.
    Bolger GT; Rafferty MF; Weissman BA; Rice KC; Skolnick P
    Pharmacol Biochem Behav; 1986 Jul; 25(1):51-7. PubMed ID: 2944131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticonvulsant and adverse effects of MK-801, LY 235959, and GYKI 52466 in combination with Ca2+ channel inhibitors in mice.
    Gasior M; Borowicz K; Kleinrok Z; Starownik R; Czuczwar SJ
    Pharmacol Biochem Behav; 1997 Apr; 56(4):629-35. PubMed ID: 9130287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.